Comparative study on the immunopotentiator effect of ISA 201, ISA 61, ISA 50, ISA 206 used in trivalent foot and mouth disease vaccine

Veterinary World

Volumn 8, Issue 10, 2015, Pages 1189-1198

  Ibrahim, Ehab El Sayed ^a   Gamal, Wael Mossad ^a   Hassan, Amr Ismail ^a   Mahdy, Safy El Din ^a   Hegazy, Akram Zakria ^a   Abdel Atty, Magdy Mahmoud ^a  

^a Agricultural Research Center   (Egypt)

Author keywords

Cellular immunity; ELISA; FMD Montanide ISA vaccines; SNT

Indexed keywords

EID: 84944722322     PISSN: 09728988     EISSN: 22310916     Source Type: Journal    
DOI: 10.14202/vetworld.2015.1189-1198     Document Type: Article

References (37)

1. Depa, P.M., Dimri, U., Sharma, M.C. and Tiwari, R. (2012) Update on epidemiology and control of foot and mouth disease - A menace to international trade and global animal enterprise. Vet. World, 5(11): 694-704.
2. Longjam, N., Deb, R., Sarmah, A.K., Tayo, T., Awachat, V.B. and Saxena, V.K. (2011) A brief review on diagnosis of foot and- mouth disease of livestock: Conventional to molecular tools. Vet. Med. Int., 2011: 905768.
3. Rodriguez, L.L. and Grubman, M.J. (2009) Foot and mouth disease virus vaccines. Vaccine, 27 Suppl 4: D90-4.
4. 50). Vet. World, 6(11): 844-851.
5. Ibrahim, E.E. (2011) Advanced studies on Foot and Mouth Disease Vaccines of sheep in Egypt. PhD. Sc. Thesis (Infectious Diseases), Faculty of Veterinary Medicine, Cairo University, Egypt.
6. TM 201 adjuvanted FMD vaccine induces improvedimmune responses and protection in cattle. Vaccine J., 31: 3327-3332.
7. Patil, P.K., Boyry, J., Ramoikrishna, C., Hugar, B., Misrol, L.D. and Natarajan, C. (2002) Immune response of goats against FMD quadrivalent vaccine: Comparison of double oil emulsion and aluminium hydroxide gel vaccine in eliciting immunity. Vaccine, 20: 2671-2789.
8. Alexandersen, S., Zhang, Z., Donaldson, A.I. and Garland, A.J. (2003) The pathogenesis and diagnosis of foot and mouth disease. J. Comp. Pathol., 129: 1-36.
9. Sutmoller, P. and Gaggero, A. (1965). Foot-and mouth diseases carriers. Vet. Rec., 77: 968-969.
10. Aidaros, H.A. (2002) Regional status and approaches to control and eradication of FMD in the Middle East and North Africa. Rev. Sci. Tech. Off. Int. Epizoot., 21(3): 451-458.
11. Farag, M.A., Aggour, M.A. and Daoud, A.M. (2005) ELISA as a rapid method for detecting the correlation between the field isolates of foot and mouth disease and the current used vaccine strain in Egypt. Vet. Med. J. Giza., 53(4): 949-955.
12. Satya, P. (2009) Vaccination against foot-and-mouth disease virus: Strategies and effectiveness. Expert Rev. Vaccines, 8(3): 347-365.
13. rd International Conference Veterinary Research Division. NRC, Cairo, Egypt, p91-100.
14. Shawky, M., Abd El-Aty, M., Fakry, H.M., Daoud, H.M., El-Sayed, I.E., Mossad, G.W., Rizk S.A., Abu-Elnaga, H., Mohamed, A.A., Abd El-Kreem, A. and Farouk, E.M. (2013) Isolation and molecular characterization of foot and mouth disease SAT2 virus during outbreak 2012 in Egypt. J. Vet. Adv., 3(2): 60-68.
15. Lombard, M., Pastoret, P.P. and Moulin, A.M. (2007) A brief of vaccines and vaccination. Rev. Sci. Tech., 26(1): 29-48.
16. 21 cells. Virol. J., 8: 169.
17. Reed, L.J. and Muench, H. (1938) A simple method of estimating 50% end points. Am. J. Hyg., 27: 493-497.
18. Health Protection Agency. (2009) Complement fixation tests. Issue No.: 3 Issue date 11.12.09 Issued by: Standards Unit, Department for Evaluations, Standards and Training page 1 of 23.
19. Killington, P.A., Stokes, A. and Hierolzer (1996) Virology Methods Manual. Ch. 4. Academic Press, New York. p72-89.
20. Barteling, S.J. and Cassim, N.I. (2004) Very fast (and safe) inactivation of FMD virus and enteroiruses by a combination of binary ethylenimine and formaldehyde. Schudel, A., Lombard, M. editors. Control of Infections Animal Disease by Vaccination. Vol. 119. Kager, Basel. p449-455.
21. Ismail, A.H., El-Mahdy, S.A., Mossad, W.G., Abd El-Krim, A.S., Abou El-Yazid, M. and Ali, S.M. (2013) Optimization of the inactivation process of FMD virus serotype SAT-2 by Binary Ethyleneimine (BEI). J. Vet. Adv., 3(3): 117-124.
22. Gamil, M.A. (2010) Studies on the immune response ofcalves vaccinated inactivated bivalent FMD virus vaccine type O/1 and A/Egypt 2006. M.V. Sc. in Veterinary Science (Virology). Benha University.
23. OIE. (2013) OIE/FAO Foot-and-Mouth Disease Reference Laboratory Network, Annual Report, 2013.
24. Muhammad, K., Chaudhry, Z.I., Rabbani, M., Altaf, I., Tariq, M.A. and Anees, M. (2011) In process quality control factors affecting potency of foot and mouth disease virus vaccine. Pak. J. Zool., 43(2): 249-254.
25. th Centropanamericano Fibre aftosa, (21/22): 17-24.
26. Voller, A., Bidwell, D. E., and Bartlett, A. (1976b). Microplate enzyme immunoassays for the immunodiagnosis of virus infections. In Manual of Clinical Immunology, Chapter 69, edited by N. Rose and H. Friedman, pp. 506-512. American Society for Microbiology.
27. Lee, L.F. (1984) Proliferative response of chicken B and T lymphocytes to mitogens. Chem. Regul. Immun. Vet. Med., 15: 44-52.
28. Bomford, R. (1997) Adjuvants in veterinary vaccines In: Mowat, N., Rweyemamu, M., editors. Vaccine Manual: The Production and Quality Control of Veterinary Vaccines for Use in Developing Countries. FAO, Rome. p277-284.
29. Dong Li, Chunxue Zhou, Daliang She, Pinghua Li, Pu Sun, Xingwen Bai, Yingli Chen, Baoxia Xie, Zaixin Liu (2013) The comparison of the efficacy of swine FMD vaccine emulsified with oil adjuvant of ISA 201 VG or ISA 206 VG, Journal of Biosciences and Medicines, 2013, 1, 22-25, http://dx.doi.org/10.4236/jbm.2013.13005
30. Barnett, P.V., Pullen, L., Warder, P. and Stathen R.(1998) International bank for FMD vaccine (preliminary studies on emergency FMD vaccines formulated with Mantonide IMS (immnuosol), a new concept in oil adjuvant), European commission for the control of FMD, Aldershot, United Kingdom,14-18, September, Appendix, 37: 268-271.
31. Fakhry, H.M., Rizk, S.A., Abu-Elnaga, H.I., Deghaidy, W., Talaat, A.A. and Hegazi, A.Z. (2012) Field application of bivalent foot and mouth disease vaccine adjuvanted with Montanide ISA (25, 50, 206) and IMS (1113-3015) as an alternative to aluminum hydroxide gel. Egypt. J. Virol., 9(1): 123-136.
32. Knudsen, R.C., Groocock, C.M. and Andersen, A.A. (1979) Immunity to foot-and-mouth disease virus in guinea pigs: Clinical and immune responses. Infect. Immun., 24(3): 787-792.
33. Sharma, S.K. (1984) Foot and mouth disease in sheep and goat. Vet. Res. J., 4(1): 1-21.
34. El-Watany, H., Shawky, M.M., Roshdy, O.M. and El-Kelany, S. (1999) Relationship between cellular and humoral immunity responses in animal vaccinated with FMD vaccine. Zagazig Vet. J., 27(1): 49-57.
35. Mansour, A. (2001) Some studies on the effect of mycotoxins on immune response of FMD vaccinated animals. Ph. D. Thesis (Infectious Diseases). Faculty of Veterinary Medicine, Cairo University.
36. Samir, M.A.A. (2002) Studies on preparation of newly oil adjuvanted FMD vaccine. Ph. D. Thesis (Virology), Faculty of Veterinary Medicine, Cairo University.
37. El-Din, W.M., Ibrahim, E.E., Daoud, H. and Ali, S.M. (2014) Humeral and cellular immune response of Egyptian trivalent foot and mouth disease oil vaccine in sheep. Res. Opin. Anim. Vet. Sci., 4(4): 178-185.